Shopping Cart
Professional article · Aesthetic medicine
PRP or hyaluronic acid filler: Which option fits which goal?
PRP and hyaluronic acid fillers are both injected, but they serve different purposes. This article compares goals, evidence, procedure, risks and duration without presenting either option as universally better.
Contents
Brief answer
- PRP is prepared from the patient’s own blood. It is intended to stimulate biological processes; research has examined changes in skin texture, fine lines and perceived skin quality, among other outcomes. The evidence shows positive signals, but it is heterogeneous and depends on the protocol.
- Hyaluronic acid fillers provide targeted volume, support tissue and alter contours. The initial effect is usually visible immediately; the final assessment is made after swelling has subsided.
- The procedures are not interchangeable: PRP does not replace volume restoration, and a filler is not equivalent to biological “regeneration” of the skin.
- A combination may be appropriate in individual cases. However, one randomised study supports only a specific PRP-HA system and does not justify a general conclusion for every product combination or injection technique.
PRP
Processed platelet-rich plasma from the patient’s own blood; its composition and platelet concentration depend on the system and protocol used.
- Primary goal
- Skin parameters
- Principle
- biological approach
- Onset of effect
- gradual
- Material
- autologous
Hyaluronic acid fillers
Usually a cross-linked, resorbable hyaluronic acid gel whose firmness and flow characteristics are selected for the relevant anatomical region.
- Primary goal
- Volume and contour
- Principle
- Tissue support
- Onset of effect
- usually immediate
- Material
- HA gel
What is PRP?
PRP stands for Platelet-Rich Plasma, or plasma with an increased platelet concentration. Blood is collected and centrifuged. The aim is to obtain a plasma fraction with a platelet concentration that differs from the baseline blood. Platelets release signalling molecules involved in wound healing and tissue responses.
However, “PRP” is not a standardised product. Platelet concentration, leukocyte content, activation, injection volume and treatment intervals vary between systems and studies. These differences make universally applicable conclusions about effects difficult.
Because the plasma fraction comes from the patient’s own blood, classic allergic reactions to the plasma itself are less likely. Risks associated with blood collection, injection, contamination, anticoagulants or other additives nevertheless remain possible.
What are hyaluronic acid fillers?
Dermal fillers are a product category. This article refers exclusively to resorbable hyaluronic acid-based fillers. They are injected into defined tissue layers to restore volume, alter contours or reduce the visible appearance of certain folds and wrinkles.
The visible effect is mainly based on spatial placement and the physical properties of the gel. Immediately after treatment, swelling and fluid accumulation may influence the result. A reliable assessment is therefore usually made only after the early reactions have subsided.
PRP and hyaluronic acid fillers compared
The most important difference is not the age of the person being treated, but the specific finding and treatment goal. The table summarises typical differences; it does not replace product information or an individual medical assessment.
| Criterion | PRP | Hyaluronic acid fillers |
|---|---|---|
| Primary goal | possible changes in individual skin parameters | volume, contour and tissue support |
| Mode of action | biological response to a platelet-rich plasma fraction | physical placement of an HA gel |
| Material | prepared from the patient’s own blood | resorbable hyaluronic acid gel |
| Visibility | possible changes develop gradually | volume effect usually immediate; assessment after swelling subsides |
| Treatment plan | often a treatment series; no universal standard protocol | depends on area, product, quantity and need for correction |
| Correctability | cannot be enzymatically “dissolved” | HA can be broken down with hyaluronidase; the effect is not identical for every product |
| Important limitation | does not replace targeted volume restoration | is not equivalent to biological tissue regeneration |
Procedure and materials
PRP preparation and application
After blood collection, the blood is centrifuged in a system intended for this purpose. Depending on the system, plasma fractions are separated, collected and used in accordance with the specified protocol. Tube type, anticoagulant, rotor geometry, relative centrifugal force, run time and handling are among the factors relevant to comparability.
Injection of a hyaluronic acid filler
The practitioner selects the product, quantity, injection plane and instrument according to the anatomy and target region. A needle or blunt cannula may be used depending on the situation. Sound anatomical knowledge, an appropriate medical history and a prepared complication-management plan are essential. Products for professional users can be found in the dermal fillercategory.
What does current research show?
The evidence for the two procedures is structured differently: PRP studies often investigate varied preparation and combination protocols. Filler studies are product- and region-specific. Results therefore cannot be transferred indiscriminately to other systems or facial areas.
Positive signals, but heterogeneous endpoints
One systematic review included nine clinical studies and two observational studies. A further meta-analysis evaluated nine RCTs involving 358 people and found benefits across pooled subjective and objective endpoints. However, the included applications, body regions and comparators were not uniform. 1 2
Volume restoration is well studied
A systematic review of midface augmentation included 14 studies; five RCTs involving 748 people were included in the meta-analysis. The data support volume augmentation, but show high heterogeneity and no clear advantage for every subjective endpoint. 6
A product-specific RCT
In a randomised study involving 93 people, a ready-made combination of autologous PRP and hyaluronic acid used on the cheeks performed better than the investigated single-treatment arms. The result does not show that every free mixture, sequence or combination is superior. 5
Important context:
A small randomised study involving 18 women found no clear advantage of PRP over saline for several measured parameters when both sides of the face also received microneedling. Individual negative or neutral studies do not necessarily rule out every possible effect, but they show why the evidence cannot be regarded as consistent.
4
Combination: possible, but not automatically better
PRP and hyaluronic acid fillers can address different goals within an individually planned treatment concept. Whether they are used at the same appointment, at different times or at all depends on the findings, products, injection planes and risk profile. The 93-person study must not be interpreted as permission to independently mix arbitrary products.
Safety and possible adverse effects
Both procedures breach the skin barrier. Temporary pain, redness, swelling, tenderness and bruising may occur. Sterile technique, correct product selection, medical history and follow-up care are therefore essential.
PRP: possible risks
- Pain, redness, swelling or bruising
- Bleeding or a circulatory reaction during blood collection
- Infection if aseptic technique is inadequate
- Reactions to anticoagulants or other system components
- Insufficient or absent visible change
HA fillers: possible risks
- Swelling, redness, bruising and tenderness
- Asymmetry, overcorrection, Tyndall effect or nodules
- Inflammatory reactions and infections
- Rare vascular occlusion with possible tissue damage
- Very rare visual disturbance, blindness or neurological complication
How long are results visible?
Visible effects of hyaluronic acid fillers are often described as lasting several months, depending on the product, quantity, region and metabolism. Figures of approximately 6 to 18 months are only rough reference values and cannot be applied to every product.
Imaging studies show that residual material in the midface may remain detectable for considerably longer. This is not the same as an unchanged visible aesthetic effect and argues against automatic reinjection based solely on the calendar. 7
There is no uniformly established duration of effect for PRP. Possible changes develop gradually; studies use different treatment series and follow-up periods. There is also no universal maintenance interval that applies to all systems.
Which procedure fits which goal?
The following guidance describes typical objectives. It is not a treatment recommendation and requires a medical assessment of the skin, anatomy, pre-existing conditions, medication and any fillers already present.
PRP may be relevant when …
- targeted volume restoration is not the primary objective
- an autologous approach is preferred
- gradual rather than immediately shaping changes are acceptable
- the limited and protocol-dependent evidence is assessed realistically
An HA filler may be relevant when …
- volume loss or contour is to be addressed selectively
- an immediately visible change in shape is desired
- product-specific duration and follow-up treatments are acceptable
- rare but serious vascular risks are understood
How much do PRP and hyaluronic acid fillers cost?
Prices depend on the region, clinic, product, quantity, number of sessions and effort involved. PRP is often offered as a treatment series; fillers are commonly calculated by product quantity or treatment area. Flat-rate price statements are therefore of limited value. For purely aesthetic indications, patients usually pay privately. Total costs, possible review appointments and follow-up costs should be clarified transparently before treatment begins.
Frequently asked questions
Is PRP or a hyaluronic acid filler better?
Neither procedure is universally better. PRP is investigated in connection with possible changes in individual skin parameters. Hyaluronic acid fillers are primarily used for targeted volume restoration and contouring. The finding and treatment goal are decisive.
Can PRP and hyaluronic acid fillers be combined?
A combination is possible in principle, but it must be planned for the specific product and patient. One RCT involving 93 people investigated a particular combined system on the cheeks. This does not establish general superiority or compatibility of arbitrary products.
Which method lasts longer?
The results cannot be compared directly. Fillers usually create volume immediately and may remain visibly effective for months depending on the product and region. There is no uniformly established duration for PRP; possible changes develop gradually.
Can a hyaluronic acid filler be dissolved completely?
Hyaluronidase can break down hyaluronic acid fillers. How quickly and completely this occurs depends on factors including the product, degree of cross-linking, location, dose and distribution of the enzyme. Complete or immediate reversal cannot be guaranteed.
What materials are required for PRP preparation?
A blood collection and PRP tube system intended for the planned workflow, a suitable centrifuge and approved accessories are required. The manufacturer’s specifications, intended purpose, RCF, run time and hygienic work instructions are decisive.
Who should perform PRP or filler injections?
Injection treatments should be carried out only by persons who are legally authorised and professionally qualified to do so. Precise anatomical knowledge and immediately available complication management are particularly important for filler procedures.
Conclusion
PRP and hyaluronic acid fillers address different tasks. A filler can selectively change volume and contour. PRP is studied as an autologous biological approach, but it cannot provide comparable volume restoration. Evidence for PRP is harder to standardise because preparation and application protocols vary. Combining the two procedures may be appropriate, but it is not automatic and has not been established generally for arbitrary products.
Professional products for clinical workflows
The following categories are intended for professional users. The manufacturer’s intended purpose, labelling and instructions for use remain decisive in every case.
Medical information: This article provides general, factual information. It does not replace an individual medical history, diagnosis, informed consent or treatment. It contains no promise of cure and no recommendation for a specific procedure or product. Benefits, risks and suitability must be assessed medically in each individual case.
How this article was reviewed
The article is based on the systematic reviews, randomised studies and safety reviews listed below. Product- and region-specific results were not generalised to other preparations or applications. Last source review: 21 July 2026.
Scientific references
- Chen H, Zhou X. Meta-Analysis of the Efficacy of Platelet-Rich Plasma in Treating Skin Aging. Aesthetic Surgery Journal Open Forum. 2026;8:ojaf150. DOI
- Rodríguez-Castro MJ, Cortés-Rodríguez AE. Efficacy of platelet-rich plasma in facial rejuvenation: A systematic review. Enferm Clin. 2025. PubMed
- Use of platelet rich plasma for skin rejuvenation. Skin Research and Technology. 2024;30:e13714. PubMed
- Evaluation of Platelet-rich Plasma and Microneedling for Facial Skin Rejuvenation. Plastic and Reconstructive Surgery – Global Open. 2024. PubMed
- Hersant B et al. Synergistic Effects of Autologous Platelet-Rich Plasma and Hyaluronic Acid Injections on Facial Skin Rejuvenation. Aesthetic Surgery Journal. 2021;41(7):NP854–NP865. DOI
- Safia A et al. Efficacy and Safety of Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review and Meta-Analysis. Medicina. 2025;61(10):1823. PubMed
- Master M. Hyaluronic Acid Filler Longevity in the Mid-face: A Review of 33 Magnetic Resonance Imaging Studies. Plast Reconstr Surg Glob Open. 2024. PubMed
- Lowe S. Hyaluronic Acid Dermal Filler-Associated Vascular Occlusion—A Review of Prevention and Management Strategies. Journal of Cosmetic Dermatology. 2026;25(5):e70884. PubMed
- Buhren BA et al. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase. Eur J Med Res. 2018;23:37. PubMed
- Niamtu J et al. Quantifying the Digestion of Cross-Linked Hyaluronic Acid Fillers With Hyaluronidase. Dermatologic Surgery. 2021. PubMed
